Labor Przedsiębiorstwo Farmaceutyczno - Chemiczne sp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2018-10-02
Share capital
186,252.00 PLN
Activity description

Labor Przedsiębiorstwo Farmaceutyczno - Chemiczne is a Polish company with over 70 years of experience in pharmaceutical and chemical production. It manufactures prescription medications, dietary supplements, and medical food, all produced in compliance with Good Manufacturing Practice (GMP) and Hazard Analysis and Critical Control Points (HACCP) standards. The company also operates its own chemical and microbiological laboratory to ensure quality control throughout the production process.

Registered address
ul. Jana Długosza 49, 51-162 Wrocław, Poland
Email
Phone
Social media
Electronic delivery address
AE:PL-12580-35558-AUAVT-26

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 78 days late).

  • 202514/07/2026
  • 202402/07/2025
  • 202301/07/2024
  • 202205/07/2023
  • 202101/10/2022
  • 202024/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Sanctions and PEP lists

PersonList
Aldona Kieler-KowalskaCzłonek organu spółki Skarbu Państwa

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Sector · Manufacturing11,938 / 24,548
Top 49%
City · Wrocław3,106 / 13,650
Top 23%
Voivodeship · Dolnośląskie6,288 / 23,831
Top 26%
Country · Poland83,219 / 297,069
Top 28%

Results vs industry

Revenue
This companyUSD 1.18mMedianUSD 913.43kAverageUSD 25.82m
Net profit
This companyUSD -314.17kMedianUSD 14.22kAverageUSD 2.77m
Operating costs
This companyUSD 1.45mMedianUSD 846.99kAverageUSD 21.42m
Assets
This companyUSD 1.22mMedianUSD 897.46kAverageUSD 31.52m

Trademarks

The company holds 11 active trademarks registered with the Polish Patent Office. The first mark was filed in 1998.

MarkNumberClassesStatusProtected until
STOPAMID (word)Z.4893605Protected Aug 13, 2028
ECHIMUNN (word)Z.4893535Protected Aug 13, 2028
ECHIMUNN C (word)Z.4893545Protected Aug 13, 2028
NEFRECIL (word)Z.4893595Protected Aug 13, 2028
WITAMUSKI (word)Z.4604575Protected Aug 18, 2036
MarkProtected until
STOPAMID (word)Aug 13, 2028
ECHIMUNN (word)Aug 13, 2028
ECHIMUNN C (word)Aug 13, 2028
NEFRECIL (word)Aug 13, 2028
WITAMUSKI (word)Aug 18, 2036

Authorized Representatives

Barbara Biłan-Żulewska age 39 – Management Board Member
Hubert Kieler age 54 – President of the Management Board

Manner of representation

If the management board is a multi-member management board, the joint action of two members of the management board or one member of the management board jointly with a commercial proxy is required to submit declarations of will on behalf of the company. In the case of a one-person management board, the sole member of the management board is authorized to submit declarations of will on behalf of the company. Two commercial proxies acting jointly are also authorized to submit declarations of will on behalf of the company, in accordance with the provisions of law.

Supervisory board

Mykolas Aniunas – Supervisory Board Member
Piotr Stelmach age 71 – Supervisory Board Member

Ownership

OwnerSharesShare valueStake
Mykolas Aniunas
416$11,461.9122.782%
208$5,730.9611.391%
208$5,730.9611.391%
755$20,802.2741.3472%
208$5,730.9611.391%
31$854.131.6978%

Aldona Kieler-Kowalska and Hubert Kieler hold a combined 52.7% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2018-10-02.

Debt

2 closed proceedings recorded in KRZ history.

Registration dateProceeding typeStatus
Jan 26, 2023
Proceedings after filing an arrangement approval application
Closed
Sep 27, 2022
Arrangement approval proceedings
Closed

Public aid

19 public aid cases recorded, with a total value of $73,765.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$5,766
De minimis aid (in accordance with Commission Regulation 2023/2831)
$5,049
De minimis aid (in accordance with Commission Regulation 2023/2831)
$677

Regulatory authorisations

AuthorityTypeStatus
Waste generation Inactive
Integrated permit Active

Competitors

Name
Fortis Pharmaceuticals sp. z o.o.
Ethifarm sp. z o.o. + limited partnership
Adpharma sp. z o.o.
Herbal Pharmaceuticals sp. z o.o.
Amara Active Healing sp. z o.o.
Bioactive T sp. z o.o.
Zakłady Chemiczno-Farmaceutyczne Vis sp. z o.o.
Plus Solinea Pharma sp. z o.o.
Vitabalans sp. z o.o.
Goodwill Pharma Polska sp. z o.o.

FAQ

Last updated: 2026-10-03